Cart
sales@molnova.com
Iodixanol
CAS No. 92339-11-2
Iodixanol( Visipaque | Acupaque )
Catalog No. M19416 CAS No. 92339-11-2
Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 62 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 61 | In Stock |
|
| 50MG | 91 | In Stock |
|
| 100MG | 145 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 384 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIodixanol
-
NoteResearch use only, not for human use.
-
Brief DescriptionIodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography.
-
DescriptionIodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography.
-
In Vitro——
-
In Vivo——
-
SynonymsVisipaque | Acupaque
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number92339-11-2
-
Formula Weight1550.18
-
Molecular FormulaC35H44I6N6O15
-
Purity>98% (HPLC)
-
SolubilityDMSO:>10 mM
-
SMILESCC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I
-
Chemical Name55'-((2-hydroxypropane-13-diyl)bis(acetylazanediyl))bis(N1N3-bis(23-dihydroxypropyl)-246-triiodoisophthalamide)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang BC et al. J Cardiol. 2014 Apr;63(4):260-8.
molnova catalog
related products
-
Tryptophan Motif Pep...
Tryptophan Motif Peptide
-
Alphalipoic acid
Thioctic acid is an octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes.
-
SynuClean-D
SynuClean-D is an α-synuclein aggregation inhibitor preventing fibril propagation, disrupting mature amyloid fibrils, and abolishing the degeneration of dopaminergic neurons in an animal model of Parkinson’s disease.
